**Specifications Table**TableSubject area*Biology*More specific subject area*Chemokine biology*Type of data*Figure, Graph*How data was acquired*Real-time PCR*Data format*Analyzed*Experimental factors*Bone marrow cells were obtained by flushing tibiae and femora of mice and non-adherent cells were expanded for three days using M-CSF to generate bone marrow derived macrophages. CD4*^*+*^*T cells were obtained from spleen of mice using CD4*^*+*^*T cell isolation kit, and activated for three days using anti-CD3 antibody, anti-CD28 antibody, and IL-2.*Experimental features*Serum starved Bone marrow derived macrophages and CD4*^*+*^*T cells were cultured with DMSO or JN-2 in the presence or absence of CXCL10 for six hours, and then mRNA expression of CXCL9 and CXCL11 was analyzed by real-time PCR. Serum starved Bone marrow derived macrophages and CD4*^*+*^*T cells were cultured with or without CXCL9 or CXCL11 for 6 hours then mRNA expression of Tnfα, Il6, and Tnfsf11 was analyzed by real-time PCR*Data source location*Seoul, Republic of Korea*Data accessibility*Data with this article*

**Value of the data**•In our earlier report, C-X-C motif chemokine 10 (CXCL10) was auto-amplified through NFκB [@bib3]. Data in this study described mRNA expression of CXCL9 and CXCL11 by CXCL10 stimuli.•In our earlier report, expression of inflammatory cytokine was increased by CXCL10 [@bib3]. Data in this study described the effect of CXCL9 and CXCL11 on mRNA expression of inflammatory cytokine.•These data provide different gene expression patterns by CXCL9, CXCL10, and CXCL11 which are ligands sharing same receptor.•Other researchers can consult this data as an example for the effect of different ligands sharing the same receptor.

1. Data {#s0005}
=======

These data presented mRNA expression of CXCL9 (Cxcl9) and CXCL11 (Cxcl11) under CXCL10 stimuli in the presence or absence of CXCR3 antagonist, JN-2, in BMMs and CD4+ T cells, analyzed by real-time PCR ([Fig. 1](#f0005){ref-type="fig"}). The mRNA expression of tumor necrosis factor alpha (TNFa; *Tnfα*), interleukin 6 (IL-6; *Il6*), and receptor activator of nuclear factor kappa-B ligand (RANKL; *Tnfsf11*) under CXCL9 or CXCL11 stimuli, was also analyzed by real-time PCR ([Fig. 2](#f0010){ref-type="fig"}).Fig. 1CXCL10 differently regulates mRNA expression of CXCL9 and CXCL11. (A, B) Serum-starved BMMs and CD4^+^ T cells were cultured with or without CXCL10 (100 ng/mL) in the presence of DMSO or JN-2 (25 μM) for 6 h. (A) *Cxcl9* and *Cxcl11* mRNA level in BMMs, was analyzed by real-time PCR. (B) *Cxcl9* and *Cxcl11* mRNA level in CD4^+^ T cells, was analyzed by real-time PCR. β-actin was used as an internal control for normalization for real-time analysis. The results shown are representative of three independent experiments (*n* = 3), and the values are expressed as mean. \*\*\**P* \< 0.001 *vs* each CXCL10-untreated cells by unpaired Student\'s *t* test.Fig. 1Fig. 2CXCL9 and CXCL11 does not affect expression of inflammatory cytokines. (A, B) Serum-starved BMMs and CD4^+^ T cells were cultured with BSA, CXCL9 (100 ng/mL), or CXCL11 (100 ng/mL) for 6 h. (A) *Tnfα* and *Il6,* and *Tnfsf11* mRNA level in BMM was analyzed by real-time PCR. (B) *Tnfα, Il6,* and *Tnfsf11* mRNA level in CD4^+^ T cell was analyzed by real-time PCR. β-actin was used as an internal control for normalization for real-time analysis. The results shown are representative of three independent experiments (*n* = 3), and the values are expressed as mean ± SD. N.S, not significant.Fig. 2

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Reagents {#s0015}
-------------

The CXCR3 antagonist *N*-(4-(5-chlorobenzo\[d\]oxazol-2-ylamino) phenyl)-4-aminobutanamide (JN-2) was synthesized and purified as described previously [@bib4]. Recombinant mouse CXCL9, CXCL10, CXCL11, and M-CSF were purchased from PeproTech (London, UK).

2.2. Cell culture {#s0020}
-----------------

Bone marrow--derived macrophages (BMMs) were prepared as described previously [@bib5]. In brief, mouse bone marrow cells were obtained from femurs and tibias and incubated in α-minimal essential medium (α-MEM; Welgene, Daegu, Korea) complete media containing 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 100 µg/mL streptomycin on 10-cm culture dishes in the presence of M-CSF (10 ng/mL) overnight. Nonadherent cells were transferred to 10-cm bacterial culture dishes and further cultured in the presence of M-CSF (30 ng/mL) for 3 days. Adherent cells were used as BMMs after the nonadherent cells were washed out.

CD4^+^ T cells were isolated from mouse spleens as described previously [@bib5]. Briefly, spleens were mashed in Hanks' balanced salt solution containing 3$\times$ antibiotics. Cells were harvested, and red blood cells were removed by ammonium-chloride-potassium lysing buffer. The remaining cells were collected and separated with a Ficoll-Histopaque (Sigma, St Louis, MO, USA) discontinuous gradient. The interface containing the cells was washed with PBS and resuspended in CD4^+^ T cell isolation buffer. Resuspended CD4^+^ T cells were purified by negative selection by using CD4^+^ T cell isolation kits (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer\'s instructions. After isolation, CD4^+^ T cells were cultured in RPMI 1640 (Welgene, Daegu, Korea) containing 10% FBS and activated using anti-CD28 antibody (2 μg/mL; eBioscience, San Diego, CA, USA) and interleukin-2 (IL-2; 50 ng/mL; PeproTech, London, UK) on the plate coated with anti-CD3 antibody (2 μg/mL; eBioscience, San Diego, CA, USA) for 3 days.

2.3. Reverse transcription and real-time polymerase chain reaction analysis {#s0025}
---------------------------------------------------------------------------

Total RNA was prepared from cells or spleens by using an RNeasy Mini kit (Qiagen, Valencia, CA) according to the manufacturer\'s instructions, and cDNA was synthesized from 2 μg of total RNA by reverse transcriptase (Superscript II Preamplification System; Gibco**-**BRL, Gaithersburg, MD). Real-time polymerase chain reaction (PCR) was performed on an ABI Prism 7500 sequence detection system using a SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and following the manufacturer\'s protocols. The ABI 7500 sequence detector was programmed with the following PCR conditions: 40 cycles of 15-s denaturation at 95 °C and 1-min amplification at 60 °C. All reactions were run in triplicate and normalized to the housekeeping gene β-actin. The evaluation of relative differences of PCR results was calculated by using the comparative cycle threshold (C~T~) method. The following primer sets were used:

mouse *Cxcl9* forward, 5′- GCACGATCCACTACAAATCCC-3′, and reverse, 5′- TCCGGATCTAGGCAGGTTTG-3′; mouse *Cxcl11* forward, 5′- GGAAGGTCACAGCCATAGCC-3′, and reverse, 5′- GATCTCTGCCATTTTGACGGC-3′ ([Fig. 1](#f0005){ref-type="fig"}).

mouse *Tnfα* forward, 5′-GACCCTCACACTCAGATCATCTTCT-3′, and reverse, 5′-CCTCCACTTGGTGGTTTGCT-3′; mouse *Il6* forward, 5′-GTCCTTCCTACCCCAATTTCC A-3′, and reverse, 5′-GGATGGTCTTGGTC mouse *Tnfsf11* forward, 5′-TGGAAGGCTCATGGTTGGAT-3′, and reverse, 5′-CATTGATGGTGAGGTGTGCA-3′ ([Fig. 2](#f0010){ref-type="fig"}).

mouse *Actb* forward, 5′-ATGTGGATCAGCAAGCAGGA-3′, and reverse, 5′-AAGGGTGTAAAACGCAGCTC- 3′.

2.4. Statistical analysis {#s0030}
-------------------------

Data are presented as the mean. Statistical analysis was performed by unpaired, two-tailed Student\'s *t* test using GraphPad Prism 5.0 (GraphPad Software, San Diego, CA). Values of *P* \< 0.05 were considered significant.
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